1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane
Structure Info
- Chemspace ID
- CSSB02533288381 (In-Stock Building Blocks)
- IUPAC Name
- 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane
- Mol formula
- C20H30BNO3
- Mol weight
- 343 Da
- Catalog Number(s)
- BBLS02533288381, BBV-332025888, EN300-55175278, bbls02533288381
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.56
- Heavy atoms count
- 25
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.65
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane (C20H30BNO3) - CSSB02533288381](/st/structure/200/9c2c0ed5e061cb617a5887fb9b035b09/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCCCCC1.png "C20H30BNO3")
- Zoom the structure
- CSSB02533288381
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB02533281875](/st/structure/200/82582d2287415391ebd04f2fb16c26ba/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCC2CCCC12.png)
![Chemical structure of rac-(3aR,6aR)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB21332841676](/st/structure/200/aede09ac4619f0105c018a62d5cd6c21/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CCC%255BC%2540%2540H%255D12%2B%257C%25261%253A20%252C24%252Cr%257C.png)
![Chemical structure of rac-(1R,6R)-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-3-azabicyclo[4.2.0]octane - CSSB21331681106](/st/structure/200/2854d9df12ff06095390b1e150312df1/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CC%255BC%2540H%255D2C1%2B%257C%25261%253A20%252C23%252Cr%257C.png)
![Chemical structure of rac-(1R,6R)-7-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-7-azabicyclo[4.2.0]octane - CSSB21331671737](/st/structure/200/46a76041d05831cb38c0514374aa313f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1C%255BC%2540H%255D2CCCC%255BC%2540%2540H%255D12%2B%257C%25261%253A19%252C24%252Cr%257C.png)
Similarity Analogs
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azepane - CSSB02526921440](/st/structure/200/d5492098767acf3642ad272dccf90130/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCCCC1.png)
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB00020613767](/st/structure/200/8e318375a2fa5fb67c8c0bb97a7b535e/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCCC1.png)
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB00000062364](/st/structure/200/669baba317bf884a2a2884d3eba6c9bd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCC1.png)
![Chemical structure of 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02495332704](/st/structure/200/b0ab47fa2fa3753c993e241ee96f7e9d/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCC1.png)
![Chemical structure of 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-1,4-oxazocane - CSSB14973663629](/st/structure/200/832c1be2f1b0d10af761ea4c8d15007f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCCOCC1.png)
![Chemical structure of 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-1,4-oxazepane - CSSB02526921700](/st/structure/200/e4ceac588d40c88d45acc4517796c335/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCCOCC1.png)
![Chemical structure of 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]morpholine - CSSB00015192221](/st/structure/200/7381d3895ae8d3394fb733077f1afda8/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529N1CCOCC1.png)
